一个miRNA-21中介的PTEN/Akt/NF-κB轴促进慢性阻塞性肺病的发病
Xiaoyan Sai1, Chu Qin1, Zixiao Zhang1
1Department of Respiratory Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214000, People's Republic of China.
微RNA-21 (miR-21) 通过通过PTEN/Akt/NF-κB通路增加亡和炎症,促进慢性阻塞性肺病 (COPD). 抑制miR-21可能为COPD提供新的治疗方法.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 慢性阻塞性肺病 (COPD) 的发病过程涉及复杂的分子机制.
- 香烟烟雾 (CS) 是COPD发展的主要病因因素.
- 微RNA-21 (miR-21) 已与COPD相关的炎症和亡过程有关.
研究的目的:
- 阐明miR-21在CS诱导的亡和COPD炎症中的作用.
- 调查PTEN/Akt/NF-κB信号通路对miR-21的影响的参与.
- 评估针对COPD中的miR-21的治疗潜力.
主要方法:
- 在COPD患者的肺组织中分析miR-21和PTEN/Akt/NF-κB通路蛋白,暴露于CS的小鼠和人类支气管上皮细胞 (HBE).
- 西方涂抹测量裂开的caspase-3表达.
- 与酶相关的免疫吸收试验 (ELISA) 用于量化IL-6和IL-8.
- 用miR-21抑制剂感染HBE细胞,用于共同培养实验.
主要成果:
- 在COPD肺组织和CS暴露模型中观察到升高的miR-21和激活的Akt/NF-κB信号.
- 抑制miR-21导致PTEN表达增加和减少Akt/NF-κB激活.
- 抑制miR-21降低了共培养细胞中的分裂酶-3,IL-6和IL-8水平.
结论:
- 通过PTEN/Akt/NF-κB通路促进细胞亡和炎症,米R-21在COPD病变发生过程中发挥着重要作用.
- 向miR-21可以恢复PTEN表达并抑制Akt/NF-κB通路.
- 调节miR-21为COPD管理提供了潜在的诊断和治疗策略.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Chronic Obstructive Pulmonary Disease-I: Introduction
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
